San Diego, CA, United States of America

Dilip Ramakant Bhumralkar




Average Co-Inventor Count = 11.0

ph-index = 9

Forward Citations = 243(Granted Patents)


Location History:

  • San Diego, CA (US) (1999 - 2012)
  • Valencia, CA (US) (2010 - 2014)

Company Filing History:


Years Active: 1999-2014

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Contributions of Dilip Ramakant Bhumralkar

Introduction

Dilip Ramakant Bhumralkar is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on novel compounds. With a total of 11 patents to his name, Bhumralkar has established himself as a key figure in the development of new therapeutic agents.

Latest Patents

Among his latest patents are the 4-methylpyridopyrimidinone compounds. These inventions are directed towards novel 4-methylpyridopyrimidinone compounds of Formula (I), including their salts, synthesis methods, and their application as inhibitors of phosphoinositide 3-kinase alpha (PI3-Kα). This work highlights his commitment to advancing medical science and improving treatment options.

Career Highlights

Bhumralkar has had a distinguished career, working with leading companies in the pharmaceutical industry. Notably, he has been associated with Pfizer Corporation and Agouron Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development efforts.

Collaborations

Throughout his career, Bhumralkar has collaborated with notable professionals in the field. Some of his coworkers include Mitchell David Nambu and Mason Alan Pairish. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Dilip Ramakant Bhumralkar's innovative contributions to the pharmaceutical industry through his patents and collaborations demonstrate his dedication to advancing medical science. His work continues to influence the development of new therapeutic agents that can benefit society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…